Neox

Early Detection of Deterioration in Preterm Neonates

Health Tech & Life Sciences
Non Active, Aug 2024 ceased to operate
Follow

Company Overview

Snapshot

Founded in January 2021, Neox operates with 1–10 employees. The company has raised $200,000 across one funding round from one investor. Neox ceased operations in August 2024.

Business overview

Neox develops an advanced AI system designed for the early detection and prediction of deterioration in neonatal intensive care units. The company's core technology provides 6-hour to 24-hour warnings, aiming to improve outcomes for neonates by enabling timely interventions. Neox operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics, serving the healthcare industry globally.

Log in to access full profile

Company Intelligence Q&A

What is Neox's primary focus?
Neox focuses on the early detection of deterioration in preterm neonates using an advanced AI system.
When was Neox founded?
Neox was founded in January 2021.
What is the status of Neox?
Neox is currently non-active and ceased to operate in August 2024.
What technology does Neox utilize?
Neox utilizes an AI algorithm, specifically deep learning, to predict deteriorations in neonatal intensive care units.
What is the total funding raised by Neox?
Neox raised a total of $200,000 across one funding round. The company's funding stage is Pre-Seed.
Log in to access full profile